Voyageur Pharmaceuticals Ltd. is Canadian public company listed on the TSX Venture Exchange under the trading symbol VM. Voyageur is focused on the development of barite and iodine Active Pharmaceutical Ingredient (API) minerals. The near-term focus is developing barium, iodine radio-contrast products and bromine based pharmaceutical products.
Voyageur’s goal is to generate the initial positive cash flow from operations using third party GMP pharmaceutical manufacturers. Voyageur has plans to build all the required infrastructure to become 100% self sufficient on all manufacturing.
Voyageur owns a 100% interest in three barium sulfate (barite) projects including two properties suitable in grade for the industrial barite marketplace, including interests in a high-grade iodine, lithium & bromine brine project located in Utah, USA.
Voyageur is moving forward with its business plan of becoming the only fully integrated company in the radio-contrast medical field, by controlling all input costs under the motto of:
“From the Earth to the Bottle”
For further information, please contact: